SCHEMBL25501013

SCHEMBL25501013

CNC(=O)c1cc2c(Oc3ccc(N)cc3)cccc2cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.51
MET P08581 3/20 0.51
AURKB Q96GD4 3/20 0.51
AURKA O14965 2/20 0.51
TEK Q02763 2/20 0.51
LCK P06239 1/20 0.51
EGFR P00533 1/20 0.49
HSD17B1 P14061 1/20 0.49
MTNR1A P48039 1/20 0.49
POLB P06746 3/20 0.46
HSD17B10 Q99714 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
NPC1 O15118 2/20 0.45
AXL P30530 2/20 0.45
FGFR1 P11362 2/20 0.44
FLT1 P17948 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19338219 0.80 HSD17B10 (0.70) KDRMETAURKBAURKATEK
SCHEMBL29558136 0.80 AXL (0.65) KDRMETAURKBAURKATEK
SCHEMBL1890635 0.80 AXL (0.65) KDRMETAURKBAURKATEK
SCHEMBL258010 0.77 BRAF (0.58) POLBALDH1A1HPGDHDAC3BRAF
SCHEMBL5664461 0.77 BRAF (0.52) HSD17B1MTNR1APOLBHSD17B10KDM4E
SCHEMBL25501011 0.76 POLB (0.56) KDRMETAURKBAURKATEK
SCHEMBL31557936 0.75 ALDH1A1 (0.47) MTNR1APOLBALDH1A1HPGDKMT2A
SCHEMBL13915644 0.74 ALDH1A1 (0.49) HSD17B10KDM4EALDH1A1KMT2AMEN1
SCHEMBL28834403 0.72 ALDH1A1 (0.50) HSD17B10KDM4EALDH1A1KMT2AMEN1
SCHEMBL2746955 0.71 KDR (0.82) KDRMETAURKBAURKATEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081253-A1 COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS EXELIXIS, INC. (US) 2023-05-11 WO disclosed